BioVeda Capital
China's Drug Farm secures $27m in first tranche of Series C
Drug Farm, a China and US-based developer of treatments for infection and immunological diseases, has raised USD27m in the first tranche of Series C funding led by Shanghai's YD Capital.
PE-backed Chinese online pharmacy completes $100m US IPO
Chinese online pharmacy operator 111 Inc – best known for its 1 Drugsstore platform – traded down slightly on its NASDAQ debut after raising $100.5 million in a scaled back IPO.
Chinese online drugstore operator targets US listing
Chinese online pharmacy operator 111 Inc, which counts ClearVue Partners, Verlinvest and BioVeda Capital among its investors, has filed for an IPO in the US.
Singapore's Aslan Pharma raises $42m in US IPO
Aslan Pharmaceutical, a Singapore-based drug developer that focuses on cancer treatments, has raised $42.2 million in its US IPO. The VC-backed company listed on the Taiwan Stock Exchange last June.